972-P: Trends in Rehospitalisation Rates for Myocardial Infarction, Heart Failure, and Stroke in People with and without Diabetes in Australia from 2012-2018

Diabetes ◽  
2021 ◽  
Vol 70 (Supplement 1) ◽  
pp. 972-P
Author(s):  
JEDIDIAH I. MORTON ◽  
JENNI ILOMAKI ◽  
STEPHEN J. WOOD ◽  
DIANNA J. MAGLIANO ◽  
JONATHAN E. SHAW
2014 ◽  
Vol 210 (4) ◽  
pp. 865-874 ◽  
Author(s):  
S. M. Kolseth ◽  
N. P. L. Rolim ◽  
Ø. Salvesen ◽  
D. O. Nordhaug ◽  
A. Wahba ◽  
...  

1968 ◽  
Vol 14 (12) ◽  
pp. 1185-1196 ◽  
Author(s):  
Leonard V Crowley

Abstract The creatine phosphokinase(CPK) test based on the method of Okinaka et al. (1) was compared with the glutamic oxalacetic transaminase (GOT) test of Reitman and Frankel (2) in patients with myocardial infarction, cardiac failure, and following various diagnostic and therapeutic procedures. The CPK method used was somewhat less discriminatory than the GOT method in detecting myocardial infarction. The CPK test possessed greater specificity, since it was not elevated in congestive cardiac failure, while the GOT test was elevated in 25% of the patients with heart failure. Therefore, the CPK test offered a real advantage when evaluating suspected infarction in the presence of cardiac failure. CPK activity may be elevated when the GOT test is normal, indicating the advantage of performing more than one enzyme procedure in suspected myocardial infarction. Both GOT and CPK were elevated in many patients following surgical operation and cardiac catheterization. No CPK elevations were encountered after electroconvulsive therapy, and CPK was only occasionally elevated following coronary arteriography.


JAMA ◽  
2013 ◽  
Vol 309 (6) ◽  
pp. 587 ◽  
Author(s):  
Harlan M. Krumholz ◽  
Zhenqiu Lin ◽  
Patricia S. Keenan ◽  
Jersey Chen ◽  
Joseph S. Ross ◽  
...  

2009 ◽  
Vol 41 ◽  
pp. 174
Author(s):  
Ole J. Kemi ◽  
Niall MacQuaide ◽  
Morten A. Hoydal ◽  
Per M. Haram ◽  
Oyvind Ellingsen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document